如何回复编辑和审稿人

专题半月谈-如何回复编辑和审稿人作者：QIN提交日期：2010-12-0906:25:55PM|访问量：713专题半月谈-如何回复编辑和审稿人2008年medjaen在论文版交流了发表SCI论文的一些小技巧=45&id=12604749&sty=1&tpg=1&age=0和发表SCI论文的一些小技巧(II)=45&id=12767562&sty=1&tpg=1&age=0后，得到战友和版主的普遍关注和高度评价。由于篇幅有限，不能对那些小技巧一一展开讨论。应战友要求，在版主的支持下，本人在此设立一个半月谈专题-如何回复编辑和审稿人实例分析。需说明以下几点：1.为了突出问题的典型性，有些“实例“已经过修饰，故已不是作者原稿（或原意）。2.修改和注解谨代表本人观点。对于同一问题可能有不同或更好的修改方法或回答方式。欢迎讨论。3.同时亦欢迎各高级战友按以下格式增加实例（请注意版权问题）。希望战友回帖时紧紧围绕主题，不要讨（争）论与主题无关的话题。论文题目：所投杂志：投稿结果：编辑/审稿人问题：作者原答：建议改答：注解请写在文中相应的地方或单独列出。15January2009（第一讲）给编辑的回复信论文题目：PharmacokineticandpharmacodynamicstudiesontheantiviruseffectsofA(一种中草药)againstvirusB（一种病毒）所投杂志：LifeSciences投稿结果：这次大修后又经过一次小修，被接受发表编辑信内容（注：有删节）：DearMr.XXX,Yourmanuscripthasbeenexaminedbytheeditorsandqualifiedreferee.WethinkthemanuscripthasmeritbutrequiresrevisionbeforewecanacceptitforpublicationintheJournal.Carefulconsiderationmustbegiventothepointsraisedinthereviewercomments,whichareenclosedbelow.Ifyouchoosetosubmitarevisionofyourmanuscript,pleaseincorporateresponsestothereviewercommentsintotherevisedpaper.Acompleterebuttalwithnomanuscriptalterationsisusuallyconsideredinadequateandmayresultinlengthyre-reviewprocedures.Aletterdetailingyourrevisionspoint-by-pointmustaccompanytheresubmission.YouwillberequestedtouploadthisResponsetoReviewersasaseparatefileintheAttachFilesarea.Weaskthatyouresubmityourmanuscriptwithin45days.Afterthistime,yourfilewillbeplacedoninactivestatusandafurthersubmissionwillbeconsideredanewmanuscript.Tosubmitarevision,goto:PleaseaccesstheGuidetoAuthorsatourwebsitetochecktheformatofyourarticle.PayparticularattentiontoourReferencesstyle.Reviewers'comments:Reviewer#1:XXXXX（略）Reviewer#2:XXXXX（略）Editorsnoteandsuggestions:（注：编辑的建议）Title:Re-writethetitletoreadmoresmoothlyincontemporaryEnglishPharmacokineticandpharmacodynamicstudiesoftheantiviraleffectsofAagainstvirusB.Abstract:Re-writetheabstracttoreadmoresmoothly.A,analkaloidisolatedfromC(注：一种中草药),wastestedforantiviralactivityagainstvirusB.BothinvitroandinvivoassaysalongwithserumpharmacologicalexperimentsshowedAtohavepotentantiviralactivity.ThepharmacokineticprofileofAinSprague/DawleyratplasmaafteroraladministrationwasmeasuredbyHPLC.Bloodsamplestakenatselectedtimepointswereanalyzedtostudypotentialchangesinantiviralpharmacodynamicsasmeasuredbyinfectivityofviruses.FromthesimilarityoftheserumconcentrationprofilesandantiviralactivityprofilesitisconcludedthatAitself,ratherthanametabolite,exertedtheeffectagainsttheviruspriortobioinactivation.TheneedforeffectiveclinicalagentsagainstvirusBandtheseresultssuggestthepossibilityofbenefitfromfurtherexperimentswithA.Theauthorsshouldchecktobesurethatthetermsbloodsamples,plasmaandserumarealwaysusedappropriatelythroughouttheabstractandtext.Introduction:somesentencescanbemadelesspassive.example1stparagraphAappearstobethemostimportantalkaloidisolatedfromtheplant,itsstructuralformulaisshowninFig1....Whileitproducedageneralinhibitionofantibodyproductionlymphocyteproliferationwasstimulated(XiaandWang,1997).ThesepharmacologicalpropertiessuggestapotentialuseinthetreatmentofviralmyocarditisagainstvirusBthatcouldbestudiedinexperimentsincellcultureandanimals.Theauthorsshouldchecktheentiremanuscriptforspellingerrors(examplegiven:inyourtextalkaloidisincorrectlyspelledalkaloid)Theauthorsshouldreadtheguidelinestotheauthorsandnotincludethefirstnameoftheauthorsbeingcitedinthetext.Inthereferencesectionthefirstnameshouldbeabbreviatedasshownintheguidelinetoauthors(thustheearliertextreferenceshouldbe(Liuetal.,2003)andtheremainingoneshouldbe(Chenetal.,2002)Theauthorsinsteadofdirectlyansweringthefirstcomplexquestionofreviewer#1mayincludethethreequestionsasfutureresearchaiminthediscussionsection.Ratherthanredrawingfiguretheauthorsmaychoosetoamendthewordingofthestatisticalanalysissectiontostatethattheresultoftablesaremeans+-SEMandforfiguresare+-SD.reviewer#1commentnumber8andreviewer#2comment3mightbesatisfiedbyinclusionofarepresentativephotoofcellsandheartshowingCPE.Remembermostreadersofthejournalhaveneverseenwhatyouaretryingtodescribe.BecauseIthinkthatyoucandealwithallofthepointsraisedIamhopingtoseearevisedmanuscriptthatyouhavecarefullycheckedforerrors.Ifyouhavequestionsor[e-mail],PhDEditor2LifeSciences作者回复信原稿：DearDr.Bahl,I’m（注：正式信函不要简写）veryappreciate（注：不适合作为给编辑回信的开始，同时有语法错误）foryourcommentsandsuggestions.I（注：实际上是学生做的）haveconductedinvivoantivirusexperimentsagain（注：要表明是应审稿人或编辑建议而作）.Miceweresacrificedon15daysand30daysafterinfection.Deathrate,heartweighttobodyweightratio(HW/BW),virustitersandpathologicslices（注：用词错误）werecalculated（注：用词不当）.ProductionofmRNAofIL-10,IFN-γandTNF-αwere（注：语法错误）measuredbyRT-PCR.Ihaverevisedthismanuscriptandespeciallypaidmuchattentiontoyourcom